Teva Pharmaceuticals USA recalls Amikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manufactured in Hungary For: Teva Pharmaceutica
Recalled June 1, 2016 · FDA recall D-0859-2016 · Teva Pharmaceuticals USA
Hazard
Presence of Particulate Matter: particulate matter identified as glass in one vial. · FDA Class I
Units
6,291 units
Sold at
Nationwide and Puerto Rico
Description
Presence of Particulate Matter: particulate matter identified as glass in one vial.
Product
Amikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manufactured in Hungary For: Teva Pharmaceuticals USA, INC. North Wales, PA 19454. Individual Pack NDC 0703-9040-01, Shelf Pack NDC 0703-9040-03
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →